Combined Haploidentical Hematopoetic Stem Cell Transplantation and Liver Transplantation in a Pediatric Patient
dc.contributor.author | Uygun, V. | |
dc.contributor.author | Aliosmanoğlu, İ. | |
dc.contributor.author | Daloğlu, H. | |
dc.contributor.author | Öztürkmen, S. | |
dc.contributor.author | Yalçın, K. | |
dc.contributor.author | Karasu, G. | |
dc.contributor.author | Yeşilipek A. | |
dc.date.accessioned | 2024-05-19T14:34:06Z | |
dc.date.available | 2024-05-19T14:34:06Z | |
dc.date.issued | 2023 | |
dc.department | İstinye Üniversitesi | en_US |
dc.description.abstract | Solid organ transplantation from the same donor is an established procedure for end-stage organ failure that developed after a previous hematopoietic stem cell transplantation (HSCT); however, it is rarely done in patients transplanted with unmanipulated haplo-HSCT. There are no pediatric reports regarding the long-term performance of organ transplantation after haplo-HSCT with post-transplant cyclophosphamide (PTCY). A juvenile myelomonocytic leukemia patient, who underwent unmanipulated haplo-HSCT with PTCY from her mother at the age of 3 years, developed chronic liver graft versus host disease (GvHD) which was refractory to specific GvHD treatment. Liver transplantation (LT) from her mother (the donor of her haplo-HSCT) was decided as the next line of treatment. LT was performed on day 540 post-HSCT, and the donor's left lateral segment was appropriately removed and attached to the recipient. The symptoms of GvHD completely regressed in a month. The patient died on day 121 after LT, because of a possible hepato-pulmonary syndrome. Organ failure can develop after allo-HSCT secondary to GvHD and therefore performing HSCT from a haplo-donor may be superior to a matched unrelated donor in terms of subsequent organ transplantation for organ failure. © 2023 Tehran University of Medical Sciences. | en_US |
dc.identifier.endpage | 295 | en_US |
dc.identifier.issn | 1735-1243 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopus | 2-s2.0-85174586850 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 291 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/4410 | |
dc.identifier.volume | 17 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Tehran University of Medical Sciences | en_US |
dc.relation.ispartof | International Journal of Hematology-Oncology and Stem Cell Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | 20240519_ka | en_US |
dc.subject | Hematopoetic Stem Cell Transplantation | en_US |
dc.subject | Liver Transplantation | en_US |
dc.subject | Post-Transplant Cyclophosphamide | en_US |
dc.title | Combined Haploidentical Hematopoetic Stem Cell Transplantation and Liver Transplantation in a Pediatric Patient | en_US |
dc.type | Article | en_US |